Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

PharmiWeb

- PMLiVE

Biogen under fire over $88,000 Vumerity annual price

Pricing pressure levelled at Tecfidera follow-up MS drug

- PMLiVE

Rethinking trials: the pros and cons of protocol amendments

Protocol amendments occur often and can be beneficial, but the steps involved can be complex

- PMLiVE

Don’t we all need to be able to change something?

Surely no one plans for a ‘life of easy’, where nothing happens. Easy sounds good, but surely life’s challenges present the opportunity to shine (even fail, with the chance to...

- PMLiVE

Antibiotic resistance: The silent pandemic

Porterhouse is proud to support World Antibiotic Awareness Week. Our article aims to improve awareness of one of the biggest threats to global health today: antibiotic resistance.

Porterhouse Medical Group

Roche Basel Switzerland

Roche agrees $1.4bn takeover of fibrosis specialist Promedior

Portfolio includes phase 2 candidate with FDA breakthrough status

Celgene building

UPDATED: BMS completes Celgene merger after FTC okay

Approval comes over ten months after acquisition announcement

- PMLiVE

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

Sanofi Genzyme’s Lemtrada and Pfizer's Xeljanz receive label restrictions

- PMLiVE

The NHS is facing shortages of lifesaving treatments, says internal document

Identifies 17 new shortages including drugs for cancer treatment

- PMLiVE

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

First wave of new molecular entities has potential to generate 14 approvals

- PMLiVE

BeiGene bags FDA approval for first product Brukinsa in lymphoma

Also the first approval for a Chinese-developed cancer drug in US

- PMLiVE

Amarin wins FDA advisory nod for Vascepa cardiovascular expansion

Approval likely for fish-oil derived drug following speedy review

- PMLiVE

Shionogi scores FDA approval for new cUTI antibiotic

Pivotal new treatment for adults with complicated urinary tract infection

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links